CCM · NYSE · ·
$3.32-4.5%Sep 29 close
From the company’s own 6-K filing.
Concord Medical Services Holdings Limited is a healthcare provider featuring a full cycle of premium oncology services including cancer diagnosis, treatment, education and prevention. The Company focuses on providing multidisciplinary cancer care in all aspects of oncology healthcare services in its cancer hospitals and equipping them with technologically advanced equipment such as the state-of-the-art proton therapy system. The Company is striving to improve the quality and accessibility of cancer care through its network of self-owned cancer hospitals and clinics as well as partnered hospitals across China.
The company’s own description, as it appears at the foot of the release.
The quote and the company description come from the 6-K Concord Medical Services Holdings Ltd filed on September 26, 2025 with its results; the table is built from its quarterly reports. Read the release on EDGAR Share prices are split- and dividend-adjusted.
Concord Medical Services Holdings Ltd has no earnings call transcript available.